This is fantastic news! :) https://www.globenewswire.com/news-release/2022/06/16/2463857/0/en/Bioasis-Acquires-Phase-2-Ready-Rare-Orphan-EGF-Assets.html

Finally people can't say "you aren't in the clinic (human dosing) with xB3" anymore.
It might not happen today (with the overall depressed market given the Fed's interest rate decision yesterday) but this opens investment in Bioasis to a new set of investors on both sides of the border.

Just the start of good things till the end of the year imo.